🇺🇸 Inderal-LA in United States

FDA authorised Inderal-LA on 19 April 1983

Marketing authorisations

FDA — authorised 19 April 1983

  • Application: NDA018553
  • Marketing authorisation holder: ANI PHARMS
  • Local brand name: INDERAL LA
  • Indication: CAPSULE, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Inderal-LA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Inderal-LA approved in United States?

Yes. FDA authorised it on 19 April 1983; FDA has authorised it.

Who is the marketing authorisation holder for Inderal-LA in United States?

ANI PHARMS holds the US marketing authorisation.